Literature DB >> 21982848

A new tool for the transfection of corneal endothelial cells: calcium phosphate nanoparticles.

Jun Hu1, Anna Kovtun, Anke Tomaszewski, Bernhard B Singer, Berthold Seitz, Matthias Epple, Klaus-Peter Steuhl, Süleyman Ergün, Thomas Armin Fuchsluger.   

Abstract

Calcium phosphate nanoparticles (CaP-NP) are ideal tools for transfection due to their high biocompatibility and easy biodegradability. After transfection these particles dissociate into calcium and phosphate ions, i.e. physiological components found in every cell, and it has been shown that the small increase in intracellular calcium level does not affect cell viability. CaP-NP functionalized with pcDNA3-EGFP (CaP/DNA/CaP/DNA) and stabilized using different amounts of poly(ethylenimine) (PEI) were prepared. Polyfect®-pcDNA3-EGFP polyplexes served as a positive control. The transfection of human and murine corneal endothelial cells (suspensions and donor tissue) was optimized by varying the concentration of CaP-NP and the duration of transfection. The transfection efficiency was determined as EGFP expression detected by flow cytometry and fluorescence microscopy. To evaluate the toxicity of the system the cell viability was detected by TUNEL staining. Coating with PEI significantly increased the transfection efficiency of CaP-NP but decreased cell viability, due to the cytotoxic nature of PEI. The aim of this study was to develop CaP-NP with the highest possible transfection efficiency accompanied by the least apoptosis in corneal endothelial cells. EGFP expression in the tissues remained stable as corneal endothelial cells exhibit minimal proliferative capacity and very low apoptosis after transfection with CaP-NP. In summary, CaP-NP are suitable tools for the transfection of corneal endothelial cells. As CaP-NP induce little apoptosis these nanoparticles offer a safe alternative to viral transfection agents.
Copyright © 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982848     DOI: 10.1016/j.actbio.2011.09.013

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  10 in total

Review 1.  Recent patents on ophthalmic nanoformulations and therapeutic implications.

Authors:  Ann-Marie Ako-Adounvo; Ramesh C Nagarwal; Lais Oliveira; Sai H S Boddu; Xiang S Wang; Surajit Dey; Pradeep K Karla
Journal:  Recent Pat Drug Deliv Formul       Date:  2014

2.  Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival.

Authors:  Vannarut Satitpitakul; Zhongmou Sun; Kunal Suri; Afsaneh Amouzegar; Kishore R Katikireddy; Ula V Jurkunas; Ahmad Kheirkhah; Reza Dana
Journal:  Am J Pathol       Date:  2018-08-07       Impact factor: 4.307

Review 3.  [Protection of corneal endothelium from apoptosis by gene and cell therapy].

Authors:  T A Fuchsluger
Journal:  Ophthalmologe       Date:  2016-06       Impact factor: 1.059

Review 4.  [Novel concepts for treatment of the corneal endothelium with nanoparticles].

Authors:  Thomas A Fuchsluger
Journal:  Ophthalmologe       Date:  2018-03       Impact factor: 1.059

5.  Effects of CD25siRNA gene transfer on high-risk rat corneal graft rejection.

Authors:  Qin Qin; Yunjie Shi; Qingqing Zhao; Dan Luo; Yuan Chen; Jing Wu; Min Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-31       Impact factor: 3.117

Review 6.  Biodegradable calcium phosphate nanoparticles for cancer therapy.

Authors:  Razieh Khalifehzadeh; Hamed Arami
Journal:  Adv Colloid Interface Sci       Date:  2020-04-10       Impact factor: 12.984

Review 7.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

Review 8.  Nanomedicine approaches for corneal diseases.

Authors:  Shyam S Chaurasia; Rayne R Lim; Rajamani Lakshminarayanan; Rajiv R Mohan
Journal:  J Funct Biomater       Date:  2015-04-30

Review 9.  Current progress in gene delivery technology based on chemical methods and nano-carriers.

Authors:  Lian Jin; Xin Zeng; Ming Liu; Yan Deng; Nongyue He
Journal:  Theranostics       Date:  2014-01-15       Impact factor: 11.556

10.  A Ternary Synergistic eNOS Gene Delivery System Based on Calcium Ion and L-Arginine for Accelerating Angiogenesis by Maximizing NO Production.

Authors:  Guiming Zhang; Shangcong Han; Lisheng Wang; Yu Yao; Kai Chen; Si Chen
Journal:  Int J Nanomedicine       Date:  2022-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.